https://www.selleckchem.com/products/odm-201.html
Overall, 92% were satisfied in the treatment group, and 78.2% in the control group. Postinjection pain occurred in 5 patients in the treatment group. This study provides Level I evidence regarding the efficacy and safety of allogeneic GF injection in patients with plantar fasciitis. However, additional studies are needed to evaluate their adverse effects, immunogenicity, and microbiological safety. Level I, prospective randomized controlled case series. Level I, prospective randomized controlled case series. The 90-day modified Rankin S
Aimer
Commentaire
Partagez
